Orris

Pleural effusion viva basics to Pg level with answers

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Loading Image
I now have all the data needed for a comprehensive PG-level viva on pleural effusion. Let me compile this into a thorough, well-organized response.

Pleural Effusion - Viva Basics to PG Level

Sources: Robbins Pathology, Murray & Nadel's Respiratory Medicine, Harrison's Principles, Frameworks for Internal Medicine, Symptom to Diagnosis, Tintinalli's Emergency Medicine, Sabiston Surgery, Goldman-Cecil Medicine

PART 1: BASICS

Q: What is the normal volume of pleural fluid?
A: No more than 15 mL of serous, relatively acellular, clear fluid lubricates the pleural surface normally. - Robbins Pathologic Basis of Disease
Q: What is a pleural effusion?
A: Accumulation of fluid in the pleural space beyond the normal 15 mL. It is a common manifestation of both primary and secondary pleural diseases, which may be inflammatory or noninflammatory. - Robbins
Q: What are the 5 mechanisms of pleural effusion?
A:
  1. Increased hydrostatic pressure - e.g., congestive heart failure
  2. Increased vascular permeability - e.g., pneumonia
  3. Decreased osmotic (oncotic) pressure - e.g., nephrotic syndrome
  4. Increased intrapleural negative pressure - e.g., atelectasis
  5. Decreased lymphatic drainage - e.g., mediastinal carcinomatosis
  • Robbins Pathologic Basis of Disease, p. 676
Pleural effusion classification flowchart
Q: What are the 2 broad types of pleural effusion?
A: Transudative and exudative.
FeatureTransudateExudate
MechanismImbalanced hydrostatic/oncotic forcesIncreased capillary permeability or impaired drainage
ProteinLowHigh
LDHLowHigh
AppearanceClear, serousCloudy, turbid
Q: What are the 3 mechanisms of transudative effusion?
A:
  1. Increased hydrostatic pressure - increase in capillary hydrostatic pressure opposes oncotic pressure, causing efflux of fluid into the pleural space (e.g., CHF)
  2. Decreased oncotic pressure - a fall in capillary oncotic pressure allows fluid to leave capillaries (e.g., nephrotic syndrome, liver failure)
  3. Diaphragmatic defect - ascitic fluid passes from the peritoneal cavity into the pleural space via small diaphragmatic defects (e.g., hepatic hydrothorax)
  • Frameworks for Internal Medicine
Q: What are the common causes of transudate?
A:
  • Congestive heart failure (most common overall cause; ~500,000 cases/year in USA)
  • Cirrhosis with hepatic hydrothorax (~5-10% of patients with cirrhosis)
  • Nephrotic syndrome
  • Hypoalbuminemia
  • Pulmonary atelectasis
  • Peritoneal dialysis
  • Constrictive pericarditis
  • Superior vena cava obstruction
Q: What are the common causes of exudate?
A:
CategoryExamples
MalignantLung carcinoma, breast carcinoma, lymphoma, mesothelioma
InfectiousParapneumonic (bacterial/empyema), TB, viral, fungal
Collagen vascularRheumatoid arthritis, SLE, Churg-Strauss
Abdominal/GIEsophageal perforation, subphrenic abscess, pancreatitis, Meigs' syndrome
OthersChylothorax, uremia, sarcoidosis, pulmonary embolism, post-CABG
  • Sabiston Textbook of Surgery
Q: Which 3 tumors cause ~75% of all malignant pleural effusions?
A: Lung carcinoma, breast carcinoma, and lymphoma. Presence of malignant effusion usually portends poor prognosis (< 6-month survival). - Harrison's Principles of Internal Medicine 22e

PART 2: CLINICAL FEATURES

Q: What are the symptoms of pleural effusion?
A:
  • Dyspnea - most common, proportional to effusion size
  • Pleuritic chest pain - sharp, worse with breathing (suggests inflammatory cause)
  • Dry cough
  • Large effusions may cause positional dyspnea
Q: What are the classic physical signs of pleural effusion?
A:
  1. Decreased/absent breath sounds over the effusion
  2. Stony dullness to percussion (most specific sign)
  3. Decreased tactile fremitus (vocal fremitus)
  4. Egophony (E to A change) just above the effusion - "E" sounds like "A"
  5. Tracheal deviation away from large effusions
  6. Decreased chest wall movement on affected side
Clinical note: Dullness to percussion has sensitivity 77%, specificity 92%; LR+ 7.7, LR- 0.27. - Symptom to Diagnosis, 4th ed.
Auscultatory percussion (percussing while listening with stethoscope) may be more sensitive and specific. - Rosen's Emergency Medicine
Q: What minimum volume of fluid is needed for detection?
A:
  • CXR (PA): ~200-300 mL (blunting of costophrenic angle)
  • CXR (Lateral decubitus): ~50-100 mL
  • Ultrasound: ~3-5 mL (most sensitive bedside tool)
  • CT scan: Very sensitive, can detect even small amounts
Q: What radiological signs are seen on CXR?
A:
  • Blunting of costophrenic angle (earliest sign)
  • Meniscus sign - concave upper border with higher laterally
  • Homogeneous opacity in lower zone with obliteration of the diaphragm
  • Tracheal/mediastinal shift away from the effusion (large effusions)
  • Subpulmonic effusion - apparently elevated hemidiaphragm, peak lateral to normal
  • Fluid in fissures ("pseudotumor")
  • On lateral decubitus: free-flowing fluid layers out (distinguishes from loculation)

PART 3: DIAGNOSTIC WORKUP (PG-LEVEL)

Q: When should you perform thoracentesis?
A: Any clinically significant pleural effusion (> 1 cm on chest film) should be sampled via thoracentesis - except in cases of heart failure where clinical suspicion is very high. If the effusion persists or diagnosis becomes uncertain, thoracentesis should follow. - Symptom to Diagnosis, 4th ed.
Q: What are Light's criteria? Why are they important?
A: Light's criteria are the most widely validated criteria to distinguish transudates from exudates. Pleural fluid is an exudate if ANY ONE of the following is present:
  1. Pleural fluid protein / serum protein > 0.5
  2. Pleural fluid LDH / serum LDH > 0.6
  3. Pleural fluid LDH > 2/3 upper limit of normal for serum LDH
Operating characteristics:
  • Sensitivity for exudate: 98%
  • Specificity: 83% (LR+: 5.76; LR-: 0.02)
  • ~17% of true transudates are misclassified as exudates (false positive)
  • Frameworks for Internal Medicine; Symptom to Diagnosis, 4th ed.
Q: How do you correct for false-positive Light's criteria?
A: If a patient clinically appears to have a transudate (e.g., known CHF, diuretic therapy) but Light's criteria classify it as an exudate, calculate the serum-effusion albumin gradient:
  • Serum albumin - Pleural fluid albumin > 1.2 g/dL → effusion is actually a transudate in virtually all cases
  • This is the most specific test for a transudative effusion (especially in patients on diuretics)
  • Frameworks for Internal Medicine, p. 664
Q: What basic tests should be sent on pleural fluid?
A:
TestPurpose
Gross appearanceColor, turbidity, viscosity
Protein + LDHLight's criteria
GlucoseLow (<60 mg/dL) suggests parapneumonic, malignancy, TB, RA
Total + differential cell countCell type narrows diagnosis
pHEmpyema if < 7.2
CytologyMalignancy (esp. adenocarcinoma)
ADATuberculosis
Gram stain + cultureInfection
TriglyceridesChylothorax if > 110 mg/dL
Q: What does the differential cell count of pleural fluid suggest?
A:
  • Neutrophil predominance (>50%) - acute process: pneumonia, pulmonary embolism, pancreatitis, intra-abdominal abscess
  • Lymphocyte predominance - chronic process: malignancy, tuberculous pleuritis, postcardiac injury syndrome (PCIS), post-CABG
  • Eosinophil predominance - drug-induced, hemothorax, asbestos exposure, eosinophilic granulomatosis with polyangiitis (EGPA/Churg-Strauss)
  • Frameworks for Internal Medicine
Q: What does the gross appearance of pleural fluid tell you?
A:
AppearanceSuggests
Straw-colored/clearTransudate
BloodyHemothorax, malignancy, PE, trauma, pneumonia
Turbid/cloudyInfection (empyema)
MilkyChylothorax (triglycerides >110 mg/dL) or pseudochylothorax
Anchovy-brown/darkAmebic liver abscess
BlackAspergillus infection
ViscousMesothelioma (high hyaluronic acid)
Q: What is the significance of pleural fluid glucose?
A: Low pleural fluid glucose (< 60 mg/dL) is suggestive of:
  • Parapneumonic effusion / empyema (most common)
  • Malignancy
  • Tuberculous pleuritis
  • Rheumatoid pleuritis (can be very low, even < 30 mg/dL)
  • Hemothorax, esophageal rupture
Q: What is the role of ADA (Adenosine Deaminase) in pleural effusion?
A: ADA is particularly abundant in T lymphocytes, which are increased in TB. It is used for diagnosis of tuberculous pleuritis:
  • ADA > 40 U/L is highly suggestive of TB pleuritis
  • ADA is a highly sensitive test - a low ADA (< 40 U/L) is useful to exclude TB
  • Can also be elevated in: empyema, lymphoma, IgG4-related pleural disease
  • Systematic reviews confirm high sensitivity/specificity for TB pleuritis
  • Murray & Nadel's; Henry's Clinical Diagnosis
Q: What is the cytology yield of pleural fluid in malignancy?
A: Variable and depends on cancer type:
  • Metastatic adenocarcinoma: sensitivity up to 70%
  • Mesothelioma: sensitivity as low as 10% (notoriously poor yield, biopsy needed)
  • Frameworks for Internal Medicine

PART 4: SPECIFIC EFFUSION TYPES (PG-LEVEL)

Q: What is empyema?
A: Pus in the pleural space. Defined as presence of frank pus in the pleural cavity. Characterized by:
  • Thick, viscous, purulent yellow-green fluid
  • Masses of neutrophils admixed with other leukocytes
  • Can accumulate up to 500-1000 mL but usually small and walled off by fibrosis
  • Most commonly from contiguous spread of organisms from intrapulmonary infection
  • Can organize into dense, tough fibrous adhesions restricting pulmonary expansion
Diagnosis: Pleural fluid pH < 7.2, glucose < 40 mg/dL, LDH very high
Management: Chest tube drainage + antibiotics; may need VATS decortication
  • Robbins Pathology; Frameworks for Internal Medicine
Q: What is hepatic hydrothorax?
A: A pleural effusion in patients with cirrhosis, in the absence of cardiopulmonary disease, attributed to small diaphragmatic defects allowing ascitic fluid to pass from the abdomen into the pleural space.
  • Affects 5-10% of patients with cirrhosis
  • 85% are right-sided (due to diaphragmatic anatomy); bilateral and left-sided also occur
  • Nearly all are transudative (unless complicated by infection = spontaneous bacterial empyema)
  • Can occur even without detectable ascites (all ascites moves to chest as produced)
  • Symptoms: dyspnea and/or cough
Management:
  • Sodium restriction + diuretics
  • TIPS (transjugular intrahepatic portosystemic shunt) - 70-80% initial response
  • Repeated thoracentesis for palliation (not chest tube - high complication risk)
  • VATS pleurodesis for refractory cases
  • Indwelling pleural catheter as bridge to liver transplantation
  • Murray & Nadel's Textbook of Respiratory Medicine
Q: What is chylothorax? How is it diagnosed?
A: Accumulation of chyle (lymph with chylomicrons) in the pleural space due to disruption of the thoracic duct.
Causes:
  • Trauma/surgical (most common - post-cardiothoracic surgery)
  • Malignancy (lymphoma most common non-traumatic cause)
  • Idiopathic
Diagnosis:
  • Milky white pleural fluid
  • Triglycerides > 110 mg/dL (diagnostic)
  • If 50-110 mg/dL - send lipoprotein electrophoresis for chylomicrons
  • Triglycerides < 50 mg/dL excludes chylothorax
Note: In chylothorax, milky appearance persists overnight; in empyema, it clears when centrifuged.
Q: What is Meigs' syndrome?
A: Triad of:
  1. Benign ovarian fibroma (or fibrothecoma)
  2. Ascites
  3. Right-sided pleural effusion
The effusion can be transudate OR exudate (systematic review shows both types). Effusion resolves after tumor removal. Elevated CA-125 can be seen - do not confuse with ovarian malignancy.
Q: What is a parapneumonic effusion? How is it classified?
A: A pleural effusion occurring in association with pneumonia, lung abscess, or bronchiectasis.
TypepHGlucoseLDHManagement
Simple/uncomplicated> 7.2> 60< 1000Antibiotics alone
Complicated< 7.2< 40> 1000Chest tube drainage
EmpyemaFrank pusVery lowVery highChest tube + VATS
Q: What are the pleural effusion findings in pulmonary embolism?
A: PE can cause a pleural effusion which is typically:
  • Small to moderate, exudative, often bloody (hemorrhagic)
  • Associated with pulmonary infarction
  • Cell count: predominantly neutrophils early
  • Effusion is NOT a common presenting feature; usually seen with parenchymal infarction
Q: What are pleural findings in SLE and rheumatoid arthritis?
A:
SLE pleuritis:
  • Most common pleuropulmonary manifestation of SLE
  • Bilateral, small to moderate exudates
  • Fluid: high protein, LDH, low complement (C3, C4)
  • LE cells may be seen
  • Responds to steroids
Rheumatoid pleuritis:
  • Usually unilateral, left-sided
  • Very low glucose (< 30 mg/dL) - distinctive
  • Very low pH
  • High LDH
  • High RF titer in fluid

PART 5: RADIOLOGY (PG-LEVEL)

Q: What CT findings distinguish malignant from benign pleural thickening?
A:
  • Malignant: nodular thickening, focal masses, irregular
  • Benign: uniform, smooth thickening
  • CT also: differentiates empyema from lung abscess, characterizes effusion morphology, detects underlying lung lesions
  • Grainger & Allison's Diagnostic Radiology
Q: What is the "split pleura sign" on CT?
A: Enhancement of both visceral and parietal pleural layers separated by the effusion, seen in empyema. Helps distinguish empyema from a lung abscess (which lacks this sign).
Q: How does ultrasound help in pleural effusion?
A:
  • Can detect as little as 3-5 mL of fluid
  • Identifies loculation (internal echoes, septations)
  • Distinguishes simple (anechoic) from complex effusions (echogenic strands suggest exudate)
  • Guides thoracentesis (reduces iatrogenic pneumothorax - most common complication of blind thoracentesis)
  • Differentiates consolidation from effusion at the bedside

PART 6: MANAGEMENT (PG-LEVEL)

Q: What are the indications for thoracentesis?
A:
  • Diagnostic: any new significant effusion (> 1 cm on CXR) of uncertain etiology
  • Therapeutic: symptomatic large effusions causing dyspnea
Contraindications (relative):
  • Coagulopathy (INR > 2, platelets < 50,000)
  • Small effusion
  • Contralateral pneumonectomy
  • Skin infection at needle site
Most common complication: Iatrogenic pneumothorax (significantly reduced with ultrasound guidance)
Q: How is malignant pleural effusion managed?
A:
  1. Observation + systemic chemotherapy - for effusions likely to respond (breast cancer, small cell lung cancer, lymphoma)
  2. Repeated thoracentesis - for limited life expectancy (temporary relief)
  3. Indwelling pleural catheter (IPC/PleuRx) - outpatient drainage, preferred for recurrent malignant effusion
  4. Talc pleurodesis - sclerosant instilled via chest tube or VATS (VATS more effective); recommended for good performance status
  5. VATS pleurectomy - for fit patients, also allows biopsy
  • Goldman-Cecil Medicine
Q: What is pleurodesis? What agents are used?
A: Obliteration of the pleural space by instilling a sclerosant that causes inflammation and symphysis of the visceral and parietal pleura.
Agents (in order of efficacy):
  1. Talc - most effective sclerosant (success ~90%)
  2. Bleomycin
  3. Doxycycline / tetracycline
  4. Silver nitrate
Requirement: The lung must be able to fully expand (trapped lung is a contraindication - fluid will not drain, pleurodesis fails)
Q: What are the physiological effects of a large pleural effusion?
A:
  • Hypoxemia - usually mild; due to mildly elevated shunt (~7%), low V/Q regions
  • Arterial PO2 ~82 mmHg with elevated A-a gradient in typical cases
  • Cardiac effects - large right-sided effusions can cause hemodynamic effects similar to tamponade (echocardiographic compression of right ventricle)
  • After thoracentesis (~700 mL removed), arterial PO2 and shunt may not significantly change immediately
  • Murray & Nadel's Textbook of Respiratory Medicine

PART 7: HIGH-YIELD PEARLS FOR PG VIVA

Q: The most common overall cause of pleural effusion? A: Congestive heart failure (~500,000 cases/year)
Q: Most common cause of unilateral pleural effusion? A: Malignancy (when unilateral and massive, always suspect malignancy)
Q: Most common malignant pleural effusion in a 40-year-old woman? A: Breast carcinoma
Q: TB effusion - typical features? A: Exudate, lymphocyte predominant, ADA > 40 U/L, glucose normal or low, protein high, often unilateral. IGRA and culture of pleural biopsy have higher yield than fluid alone.
Q: What is "pseudochylothorax" / cholesterol effusion? A: Chronic, long-standing effusion (TB, RA, trapped lung) with cholesterol crystals giving milky appearance. Triglycerides < 110 mg/dL, cholesterol > 200 mg/dL. No chylomicrons.
Q: What is "loculated effusion"? A: An effusion that does not flow freely within the pleural cavity. Confirmed by: lateral decubitus CXR (fluid does not layer), ultrasound (septa/echogenic strands), CT. Common with empyema, hemothorax, malignancy.
Q: Trapped lung - what is it? Effect on effusion? A: Encasement of lung by fibrous peel preventing expansion. Pleural effusion is typically a borderline exudate (protein ratio ~0.5, LDH ratio ~0.6). Volume is constant over serial imaging. Pleurodesis will fail (lung cannot expand to touch parietal pleura). Treatment: decortication.
Q: What is Serum-Effusion Albumin Gradient (SEAG)? A: Serum albumin - Pleural fluid albumin. If SEAG > 1.2 g/dL, the effusion is a transudate. Used to correct false-positive Light's criteria in patients on diuretics.
Q: Most common complication of thoracentesis? A: Iatrogenic pneumothorax. Dramatically reduced with ultrasound guidance.
Q: What is re-expansion pulmonary edema? A: Pulmonary edema occurring after rapid drainage of a large pleural effusion (usually > 1.5 L). Caused by sudden re-expansion of a chronically collapsed lung. Prevented by limiting drainage to < 1.5 L per session.

Summary Table: Transudate vs. Exudate

FeatureTransudateExudate
Protein ratio (PF/serum)< 0.5> 0.5
LDH ratio (PF/serum)< 0.6> 0.6
PF LDH< 2/3 ULN> 2/3 ULN
GlucoseNormalLow (if empyema, RA, TB, malignancy)
pHNormalLow (if empyema, RA)
Cell typeFew cellsVaries (neutrophils, lymphocytes)
AppearanceClearTurbid/cloudy
Protein (absolute)< 3 g/dL> 3 g/dL
SEAG> 1.2 g/dL< 1.2 g/dL
Sources: Robbins & Cotran Pathologic Basis of Disease; Murray & Nadel's Textbook of Respiratory Medicine; Harrison's Principles of Internal Medicine 22e; Frameworks for Internal Medicine; Symptom to Diagnosis, 4th ed.; Tintinalli's Emergency Medicine; Sabiston Textbook of Surgery; Goldman-Cecil Medicine; Grainger & Allison's Diagnostic Radiology
This is a shared conversation. Sign in to Orris to start your own chat.